Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2021
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
22,975
-80.44%
|
$3,078,650
$134.64 P/Share
|
|
May 03
2021
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
22,975
+44.58%
|
$1,952,875
$85.13 P/Share
|
|
May 03
2021
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
132,151
-52.06%
|
$17,708,234
$134.61 P/Share
|
|
May 03
2021
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
132,151
+34.24%
|
$11,232,835
$85.13 P/Share
|
|
Apr 22
2021
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
12,872
-29.73%
|
$1,737,720
$135.47 P/Share
|
|
Apr 21
2021
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
2,285
-28.5%
|
$313,045
$137.99 P/Share
|
|
Apr 21
2021
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
10,383
-26.35%
|
$1,422,471
$137.99 P/Share
|
|
Apr 21
2021
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,750
-21.03%
|
$513,750
$137.14 P/Share
|
|
Apr 01
2021
|
Andre Schulten Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
571
-2.3%
|
$75,943
$133.53 P/Share
|
|
Mar 09
2021
|
Bertrand Marc Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+50.0%
|
-
|
|
Mar 09
2021
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
238
+0.51%
|
-
|
|
Mar 09
2021
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+1.01%
|
-
|
|
Mar 09
2021
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+2.53%
|
-
|
|
Mar 09
2021
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
238
+1.09%
|
-
|
|
Mar 09
2021
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+0.84%
|
-
|
|
Mar 09
2021
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
238
+5.23%
|
-
|
|
Mar 09
2021
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
278
+0.33%
|
-
|
|
Mar 09
2021
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.8%
|
-
|
|
Feb 26
2021
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
7,880
-8.01%
|
$985,000
$125.77 P/Share
|
|
Feb 26
2021
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
433
-7.19%
|
$54,125
$125.77 P/Share
|
|
Feb 26
2021
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
6,536
-2.58%
|
$817,000
$125.77 P/Share
|
|
Feb 26
2021
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
2,066
-10.75%
|
$258,250
$125.77 P/Share
|
|
Feb 26
2021
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
9,385
-10.04%
|
$1,173,125
$125.77 P/Share
|
|
Feb 26
2021
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,686
-5.83%
|
$3,835,750
$125.77 P/Share
|
|
Feb 26
2021
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
SELL
Open market or private sale
|
Direct |
1,691
-11.2%
|
$211,375
$125.77 P/Share
|
|
Feb 26
2021
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
7,241
-2.88%
|
$905,125
$125.77 P/Share
|
|
Feb 26
2021
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
6,903
-7.12%
|
$862,875
$125.77 P/Share
|
|
Feb 26
2021
|
Steven D Bishop CEO - Health Care |
SELL
Open market or private sale
|
Direct |
3,173
-5.13%
|
$396,625
$125.77 P/Share
|
|
Feb 26
2021
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Open market or private sale
|
Direct |
1,811
-6.9%
|
$226,375
$125.77 P/Share
|
|
Feb 17
2021
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
422,628
-2.3%
|
$54,096,384
$128.84 P/Share
|
|
Feb 16
2021
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
107,372
-1.14%
|
$13,743,616
$128.0 P/Share
|
|
Feb 03
2021
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
408,880
-4.16%
|
$52,336,640
$128.71 P/Share
|
|
Jan 21
2021
|
Marc S. Pritchard Chief Brand Officer |
SELL
Open market or private sale
|
Direct |
95,163
-42.34%
|
$12,371,190
$130.65 P/Share
|
|
Jan 21
2021
|
Marc S. Pritchard Chief Brand Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,163
+29.75%
|
$5,995,269
$63.05 P/Share
|
|
Dec 15
2020
|
David S Taylor Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-0.32%
|
$353,600
$136.85 P/Share
|
|
Dec 15
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
184
+0.07%
|
$25,024
$136.85 P/Share
|
|
Dec 15
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Payment of exercise price or tax liability
|
Direct |
1,306
-0.34%
|
$177,616
$136.85 P/Share
|
|
Dec 15
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+0.06%
|
$11,152
$136.85 P/Share
|
|
Dec 15
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-0.24%
|
$49,912
$136.85 P/Share
|
|
Dec 15
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+0.13%
|
$9,112
$136.85 P/Share
|
|
Dec 15
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Payment of exercise price or tax liability
|
Indirect |
4
-0.04%
|
$544
$136.85 P/Share
|
|
Dec 15
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Payment of exercise price or tax liability
|
Direct |
38
-0.08%
|
$5,168
$136.85 P/Share
|
|
Dec 15
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Exercise of conversion of derivative security
|
Direct |
38
+0.08%
|
$5,168
$136.85 P/Share
|
|
Dec 15
2020
|
Mary Theresa Grabowski Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-2.09%
|
$5,576
$136.85 P/Share
|
|
Dec 15
2020
|
Mary Theresa Grabowski Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41
+2.05%
|
$5,576
$136.85 P/Share
|
|
Dec 15
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
237
-0.96%
|
$32,232
$136.85 P/Share
|
|
Dec 15
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-0.2%
|
$105,672
$136.85 P/Share
|
|
Dec 15
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
115
+0.09%
|
$15,640
$136.85 P/Share
|
|
Dec 15
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.18%
|
$12,784
$136.85 P/Share
|
|
Dec 15
2020
|
Steven D Bishop CEO - Health Care |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-0.25%
|
$41,480
$136.85 P/Share
|